Advertisement
MCP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     



This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Glossary
Google Scholar
Right arrow Articles by Priego-Capote, F.
Right arrow Articles by Sanchez, J.-C.
PubMed
Right arrow Articles by Priego-Capote, F.
Right arrow Articles by Sanchez, J.-C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on September 21, 2009
Accepted on November 5, 2009

Glycation isotopic labelling (GIL) with 13C-reducing sugars for quantitative analysis of glycated proteins in human plasma

Feliciano Priego-Capote, Alexander Scherl, Markus Mu¨ller, Patrice Waridel, Frédérique Lisacek, and Jean-Charles Sanchez

Structural Biology and Bioinformatics, Geneva University, Geneva 4, Geneva 1211

Corresponding Author: jean-charles.sanchez{at}unige.ch

Non-enzymatic glycation of proteins is a post-translational modification produced by a reaction between reducing sugars and amino groups located in lysine and arginine residues or in N-terminal position. This modification plays a relevant role in medicine and food industry. In the clinical field, this undesired role is directly linked to blood glucose concentration and, therefore, to pathological conditions derived from hyperglycaemia (> 11 mM glucose) such as diabetes mellitus or renal failure. An approach for qualitative and quantitative analysis of glycated proteins is here proposed to achieve the three information levels for their complete characterization. These are: (1) identification of glycated proteins, (2) elucidation of sugar attachment sites and (3) quantitative analysis to compare between glycaemic states. Qualitative analysis was carried out by tandem mass spectrometry after endoproteinase Glu-C digestion and boronate affinity chromatography for isolation of glycated peptides. For this purpose, two MS operational modes were used: HCD-MS2 and CID-MS3 by neutral loss scan monitoring of two selective neutral losses (162.05 and 84.04 Da for the glucose cleavage and an intermediate rearrangement of the glucose moiety). On the other hand, quantitative analysis was based on labelling of proteins with 13C6-glucose incubation in order to evaluate the native glycated proteins labelled with 12C6-glucose. As glycation is chemo-selective, it is exclusively occurring in potential targets for in vivo modifications. This approach, named Glycation Isotopic Labelling (GIL), enabled to differentiate glycated peptides labelled with both isotopic forms resulting from enzymatic digestion by mass spectrometry (6 Da mass shift/glycation site). The strategy was then applied to a reference plasma sample revealing the detection of 50 glycated proteins and 161 sugar attachment positions with identification of preferential glycation sites for each protein. A predictive approach was also tested to detect potential glycation sites under high glucose concentration.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2009 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement